Cerebrospinal Fluid Management Comprehensive Study by Application (Meningitis, Encephalitis, Neurosyphilis, Subarachnoid haemorrhage, Multiple sclerosis, Guillain-Barré syndrome, Meningeal carcinomatosis), By Products (Shunts (Ventriculoperitoneal, Ventriculoatrial, Adjustable Valve), External Drainage Systems (EVD, Lumbar Drainage)), End User (Pediatric, Adult, Geriatric) Players and Region - Global Market Outlook to 2026

Cerebrospinal Fluid Management Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Cerebrospinal Fluid Management Market Scope?
Cerebrospinal fluid (CSF) is a clear fluid that surrounds the brain and spinal cord. It cushions the brain and spinal cord from injury and also serves as nutrient delivery and waste removal system for the brain. A watery fluid that is continuously produced and absorbed and that flows in the ventricles within the brain and around the surface of the brain and spinal cord. According to the research among the 1.1 million who face head injury, 235,000 people will be hospitalized with a moderate to extreme head injury while roughly 50,000 face death. Notwithstanding, a larger part of them will have a gentle physical issue that doesn't need admission to the medical clinic. With such expansion in the number of mental wounds, the CSF gadgets market will keep on developing.

The Cerebrospinal Fluid Management market study is being classified, by Application (Meningitis, Encephalitis, Neurosyphilis, Subarachnoid haemorrhage, Multiple sclerosis, Guillain-Barré syndrome and Meningeal carcinomatosis) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Players from United States and Germany will contribute to the maximum growth of Global Cerebrospinal Fluid Management market throughout the predicted period.

Medtronic (United States), Integra (France), DePuy Synthes(United States), B.Braun (Germany), Spiegelberg GmbH & Co. KG(Germany), Sophysa (Belgium), Natus Medical Incorporated (United States), Moller Medical GMBH (Germany) and G. SURGIWEAR LTD (India) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Dispomedica gmbh, Deltasurgical, Argi Grup and Wellong Instruments Co., Ltd..

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Cerebrospinal Fluid Management market by Type, Application and Region.

On the basis of geography, the market of Cerebrospinal Fluid Management has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

In March 2021 FDA grants a breakthrough nod to Anuncia’s cerebral spinal fluid treatment. Anuncia announced that the company has received FDA breakthrough device designation for its ReFlow system for cerebral spinal fluid (CSF) management.
"According to section 21, subsection 510K certain convention must be followed before CSF devices can be affirmed. The organizations need to list down any potential dangers to wellbeing and measures taken by them so the gadget tends to such wellbeing risks. Aside from this a cover sheet expressing that the device is a class II gadget, a concise portrayal of the device and a synopsis report of what the gadget does and the extent of the device should be appropriately expressed. The last advance checks the device for biocompatibility, execution and suitable naming, for example, termination dates, remedies and so forth The severe administrative rules may set aside effort for the item delivery and increment the general advancement cost of the item, consequently affecting the market."

Influencing Market Trend
  • The use of advanced technologies for the improvement in the Cerebrospinal Fluid Management devices

Market Drivers
  • High Prevalence of Hydrocephalus and the Subsequent Increase in the Number of Shunting Procedures
  • Increasing Geriatric Population
  • The rise in the number of brain surgeries drives the market for cerebrospinal fluid management

Opportunities
  • Growing Healthcare Market in Developing Economies
  • The increase in the number of brain surgeries

Restraints
  • Misdiagnosed Cerebrospinal Fluid Management can be led to the death
  • The high possibility of the failure of the device being used

Challenges
  • The dearth of Trained Professionals


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Cerebrospinal Fluid Management Manufacturer, Government Regulatory and Research Organizations and End-Use Industry

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Application
  • Meningitis
  • Encephalitis
  • Neurosyphilis
  • Subarachnoid haemorrhage
  • Multiple sclerosis
  • Guillain-Barré syndrome
  • Meningeal carcinomatosis
By By Products
  • Shunts (Ventriculoperitoneal, Ventriculoatrial, Adjustable Valve)
  • External Drainage Systems (EVD, Lumbar Drainage)

By End User
  • Pediatric
  • Adult
  • Geriatric

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Prevalence of Hydrocephalus and the Subsequent Increase in the Number of Shunting Procedures
      • 3.2.2. Increasing Geriatric Population
      • 3.2.3. The rise in the number of brain surgeries drives the market for cerebrospinal fluid management
    • 3.3. Market Challenges
      • 3.3.1. The dearth of Trained Professionals
    • 3.4. Market Trends
      • 3.4.1. The use of advanced technologies for the improvement in the Cerebrospinal Fluid Management devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Cerebrospinal Fluid Management, by Application, By Products, End User and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Cerebrospinal Fluid Management (Price)
  • 6. Cerebrospinal Fluid Management: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Medtronic (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Integra (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. DePuy Synthes(United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. B.Braun (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Spiegelberg GmbH & Co. KG(Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Sophysa (Belgium)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Natus Medical Incorporated (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Moller Medical GMBH (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. G. SURGIWEAR LTD (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Cerebrospinal Fluid Management Sale, by Application, By Products, End User and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Cerebrospinal Fluid Management (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Company Basic Information, Sales Area and Its Competitors
  • Table 2. Company Basic Information, Sales Area and Its Competitors
  • Table 3. Company Basic Information, Sales Area and Its Competitors
  • Table 4. Company Basic Information, Sales Area and Its Competitors
  • Table 5. Company Basic Information, Sales Area and Its Competitors
  • Table 6. Company Basic Information, Sales Area and Its Competitors
  • Table 7. Company Basic Information, Sales Area and Its Competitors
  • Table 8. Company Basic Information, Sales Area and Its Competitors
  • Table 9. Company Basic Information, Sales Area and Its Competitors
  • Table 10. Research Programs/Design for This Report
  • Table 11. Key Data Information from Secondary Sources
  • Table 12. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Cerebrospinal Fluid Management share by Players 2020 (%)
  • Figure 5. Global Cerebrospinal Fluid Management share by Players (Top 3) 2020(%)
  • Figure 6. Global Cerebrospinal Fluid Management share by Players (Top 5) 2020(%)
  • Figure 7. BCG Matrix for key Companies
  • Figure 8. Medtronic (United States) Revenue, Net Income and Gross profit
  • Figure 9. Medtronic (United States) Revenue: by Geography 2020
  • Figure 10. Integra (France) Revenue, Net Income and Gross profit
  • Figure 11. Integra (France) Revenue: by Geography 2020
  • Figure 12. DePuy Synthes(United States) Revenue, Net Income and Gross profit
  • Figure 13. DePuy Synthes(United States) Revenue: by Geography 2020
  • Figure 14. B.Braun (Germany) Revenue, Net Income and Gross profit
  • Figure 15. B.Braun (Germany) Revenue: by Geography 2020
  • Figure 16. Spiegelberg GmbH & Co. KG(Germany) Revenue, Net Income and Gross profit
  • Figure 17. Spiegelberg GmbH & Co. KG(Germany) Revenue: by Geography 2020
  • Figure 18. Sophysa (Belgium) Revenue, Net Income and Gross profit
  • Figure 19. Sophysa (Belgium) Revenue: by Geography 2020
  • Figure 20. Natus Medical Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 21. Natus Medical Incorporated (United States) Revenue: by Geography 2020
  • Figure 22. Moller Medical GMBH (Germany) Revenue, Net Income and Gross profit
  • Figure 23. Moller Medical GMBH (Germany) Revenue: by Geography 2020
  • Figure 24. G. SURGIWEAR LTD (India) Revenue, Net Income and Gross profit
  • Figure 25. G. SURGIWEAR LTD (India) Revenue: by Geography 2020
List of companies from research coverage that are profiled in the study
  • Medtronic (United States)
  • Integra (France)
  • DePuy Synthes(United States)
  • B.Braun (Germany)
  • Spiegelberg GmbH & Co. KG(Germany)
  • Sophysa (Belgium)
  • Natus Medical Incorporated (United States)
  • Moller Medical GMBH (Germany)
  • G. SURGIWEAR LTD (India)
Additional players considered in the study are as follows:
Dispomedica gmbh , Deltasurgical, Argi Grup , Wellong Instruments Co., Ltd.
Select User Access Type

Key Highlights of Report


Mar 2021 240 Pages 84 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Cerebrospinal Fluid Management Market Report?